Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
A randomised clinical trial to assess the impact of group singing on health for people with chronic obstructive pulmonary disease (COPD).
Description: A well-established, supervised, self-completion health status questionnaire. This consists of eight sections for which a score of 0 to 100 is created, with 0 being maximum disability and 100 equivalent to no disability.
Measure: Change from Baseline in Short Form 36 tool (SF-36) Time: At baseline, then repeated after 12 weeks.Description: a disease specific health status measure. This includes 8 items, scored 0-5 with a possible score from 0 (best) to 40 (worst).
Measure: Changes in COPD assessment test (CAT) Time: At baseline, then repeated after 12 weeks.Description: Self-administered questionnaire to assess for symptoms, and severity, of anxiety. Includes seven questions scored from 0 to 3, giving a total score out of 21. Lower scores indicate less symptoms of anxiety.
Measure: Changes in Generalised Anxiety Disorder Assessment (GAD-7) Time: At baseline, then repeated after 12 weeks.Description: Self-administered questionnaire to assess for symptoms, and severity, of depression. Includes nine questions scored from 0 to 3, giving a total score out of 27. Lower scores indicate less symptoms of depression.
Measure: Changes in Patient Health Questionnaire 9 (PHQ-9) Time: At baseline, then repeated after 12 weeks.Description: Assessment of dyspnoea. Includes 12 descriptors scored from 0 to 3, giving a total score of 36. Lower scores indicate less severe dyspnoea.
Measure: Changes in Dyspnoea-12 questionnaire Time: At baseline, then repeated after 12 weeks.Description: Distance walked in 6 minutes. Tests exercise capacity. To be performed in accordance with ATS/ERS guidelines including a practice walk.
Measure: Changes in Six-minute walk test Time: At baseline, then repeated after 12 weeks.Description: This involves a one week recall questionnaire and McRoberts MoveMonitor device physical activity monitor.
Measure: Changes in PROactive physical activity in COPD tool (cPPAC) Time: At baseline, then repeated after 12 weeks.Description: Balance confidence during activities of daily living, assessed using self-reported questionnaire. 16 item scale which gives a total balance confidence score of 0 to 100. Lower scores indicate less confidence.
Measure: Changes in Activities-specific Balance Confidence scale Time: At baseline, then repeated after 12 weeks.Description: Physical performance evaluated using the SPPB (instrumented with the McRoberts fixed-body sensor MoveTest device). Consists of 4 performance tasks (balance, walk speed and sit-to-stand) scored from 0 to 4, giving a total score out of 12 for SPPB.
Measure: Changes in Short Physical Performance Battery (SPPB) Time: At baseline, then repeated after 12 weeks.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports